XML 47 R34.htm IDEA: XBRL DOCUMENT v3.24.4
Common Stock, Stock Options and Warrants (Details) - USD ($)
12 Months Ended
Sep. 25, 2024
Apr. 30, 2024
Apr. 25, 2024
Jan. 17, 2024
Oct. 10, 2023
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2021
Aug. 07, 2024
Apr. 02, 2024
Apr. 29, 2023
Common Stock, Stock Options and Warrants [Line Items]                        
Fair value of common stock issued (in Dollars)             $ 284,176 $ 102,000        
Direct offering common shares   857,143                    
Shares of common stock             2,945,337          
Purchase price (in Dollars per share)   $ 17.5                    
Proceeds from issuance of warrants (in Dollars)   $ 15,000,002                    
Exercise price of warrants (in Dollars per share)             $ 6.25          
Agent fee (in Dollars)             $ 84,735          
Options outstanding           532,207 656,084 532,207        
Options shares were exercised             2,125          
Options to purchase shares forfeited             40,398          
Option granted shares             166,400          
Weighted average grant date fair value vested per share (in Dollars per share)             $ 13.38 $ 24.44        
Term of options outstanding           7 years 4 months 28 days 7 years 3 months 3 days          
Weighted average exercise price per share (in Dollars per share)             $ 17.5          
Shares exercisable             347,618          
Exercisable option vested period             36 months          
Vested option term             6 years 3 months 7 days          
Stock-based compensation expense (in Dollars)             $ 11,839,678 $ 6,616,705        
Dividends (in Dollars) $ 350,241                      
Expire term             5 years          
Common Stock Offerings [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Shares of common stock   857,143                    
Exercise price of warrants (in Dollars per share)   $ 18.75                    
Warrants [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Shares of common stock 111,732                 156,863 9,605  
Exercise price of warrants (in Dollars per share)                     $ 48.28  
Dividends (in Dollars)             $ 375,511          
Expire term 2 years 10 months 17 days                      
August 2018 Offering Agent [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Shares of common stock             7,576          
Exercise price of warrants (in Dollars per share)             $ 39.84          
Maturity date             Aug. 08, 2024          
September 2019 Offering Underwriter [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Shares of common stock             7,774          
Exercise price of warrants (in Dollars per share)             $ 27.97          
Maturity date             Sep. 27, 2024          
Stock Option Plans [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Term of options outstanding             10 years 10 years        
Unrecognized total compensation (in Dollars)             $ 2,678,274          
Minimum [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Term of options outstanding             12 months 12 months        
Maximum [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Term of options outstanding             36 months 36 months        
2014 Stock Incentive Plan [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Common shares reserved             34,667          
Options outstanding             18,484          
Options shares were exercised             2,318          
Options to purchase shares forfeited             13,865          
2018 Omnibus Stock Incentive Plan [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Common shares reserved             80,000          
Options outstanding             67,200          
Options shares were exercised             4,667          
Options to purchase shares forfeited             3,733          
2020 Omnibus Stock Incentive Plan [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Options outstanding             4,400          
2020 Plan [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Common shares reserved             124,400          
Options outstanding             66,000          
Options to purchase shares forfeited             8,800          
2021 Omnibus Stock Incentive Plan [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Options outstanding             49,600          
2021 Stock Plan [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Common shares reserved             349,600          
Options outstanding             330,000          
Options to purchase shares forfeited             18,200          
2023 Omnibus Stock Incentive Plan [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Options outstanding             1,400          
2023 Stock Plan [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Common shares reserved             481,400          
Options outstanding             174,400          
Options to purchase shares forfeited             4,000          
Option granted shares             303,000          
Citius Oncology plan [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Common shares reserved                       15,000,000
Contractual term for vesting period             10 years          
Unrecognized total compensation (in Dollars)             $ 11,592,383          
Recognized over a weighted average period             1 year 9 months 7 days          
Price per share (in Dollars per share)             $ 1.66          
Stock-based compensation expense (in Dollars)               $ 1,965,500        
Citius Oncology plan [Member] | Stock Option Plans [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Recognized over a weighted average period             1 year 5 months 8 days          
Citius Oncology plan [Member] | Minimum [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Vesting period             12 months          
Citius Oncology plan [Member] | Maximum [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Vesting period             36 months          
NoveCite plan [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Common shares reserved             2,000,000          
Options outstanding             1,911,500          
Term of options outstanding             6 years 4 months 20 days          
Available for future grants             88,500          
Vested option term             10 years          
Stock-based compensation expense (in Dollars)             $ 47,574 $ 130,382        
Board of Directors [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Options to purchase shares forfeited                 88,500      
Option granted shares                 2,000,000      
Contractual term for vesting period             10 years          
Weighted average exercise price per share (in Dollars per share)                 $ 0.24      
Shares exercisable             1,911,500          
Common Stock [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Common stock shares issued     6,000 5,128 4,351              
Shares of common stock                     51,780  
Exercise price of warrants (in Dollars per share) $ 19.25                 $ 28.75 $ 35.5  
Common Stock [Member] | Warrants [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Dividends (in Dollars)             $ 321,559          
Common Stock [Member] | August 2018 Offering Agent [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Shares of common stock                   7,576    
Exercise price of warrants (in Dollars per share)                   $ 39.84    
Common Stock [Member] | September 2019 Offering Underwriter [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Shares of common stock 7,774                      
Exercise price of warrants (in Dollars per share) $ 27.97                      
Common Stock [Member] | Citius Oncology plan [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Stock-based compensation expense (in Dollars)             7,498,817          
Common Stock [Member] | Investor [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Fair value of common stock issued (in Dollars)     $ 109,950 $ 98,079 $ 76,146              
Common Stock Offerings [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Exercise price of warrants (in Dollars per share)   $ 21.875                    
Maturity date   Apr. 25, 2029                    
Warrants issued (in Dollars)   $ 756,000                    
Net proceeds (in Dollars)   13,718,951         $ 162,000          
Agent fee (in Dollars)   1,050,000                    
Placement agent expenses (in Dollars)   135,000                    
Legal fee (in Dollars)   80,101                    
Other offering expenses (in Dollars)   $ 15,950                    
Warrants to purchase common shares   60,000                    
Common Stock Offerings [Member] | Investor [Member]                        
Common Stock, Stock Options and Warrants [Line Items]                        
Maturity date   Oct. 30, 2029                    
Warrants issued (in Dollars)   $ 11,206,000